We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Wristwatch-Like Device Automates Drug Delivery

By Biotechdaily staff writers
Posted on 27 Sep 2004
A new drug delivery device, worn like a wristwatch, can be programmed to administer drug doses into the body automatically, at different times of the day and in varying doses, whether the patient is asleep or awake.

Called ChronoDose, the system is most effective for treating heart disease, depression, asthma, attention-deficit disorder, hypertension, and arthritis, according to the marketer, Chrono Therapeutics, Inc. (Nanuet, NY, USA). The device can be programmed to release drugs when disease symptoms are statistically worst, to increase the effectiveness of therapy. The device is capable of precisely tailored drug delivery where noninvasive, automated administration of a precise drug at a precise time was previously impossible.

ChronoDose was developed by the University of Basel, the University of Applied Science of Basel, and the University of Applied Science of Solothurn (all in Switzerland) in association with Chrono Therapeutics.

Our ChronoDose system will help ease patient suffering by managing peak disease symptoms with far greater efficacy and fewer side effects than any other system available today, noted Guy DiPierro, founder and president of Chrono Therapeutics.


Related Links:
Chrono Therapeutics

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
New
Alzheimer's Disease Biomarker Assay
Elecsys Phospho-Tau (217P) Plasma
New
Nucleic Acid Purification Instrument
QIAsymphony Connect

Latest BioResearch News

Genetic Study Links Inherited Blindness to Gene Tied to Rare Metabolic Disorder
27 Sep 2004  |   BioResearch

Population-Scale Proteomics Study Identifies New Genetic-Protein Links
27 Sep 2004  |   BioResearch

Circulating Tumor DNA Helps Identify Targets for Personalized Immunotherapy
27 Sep 2004  |   BioResearch